Atlas Trials

Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age

Clinical trial NCT00192140 · COMPLETED

Trial details

NCT number
NCT00192140
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Influenza
Start date
2004-06-01
Primary completion
2004-10-01
Enrollment
345

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.